Venous thromboembolism in patients with HIV/AIDS: a case-control study.

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
JAIDS Journal of Acquired Immune Deficiency Syndromes (Impact Factor: 4.39). 07/2008; 48(3):310-4. DOI: 10.1097/QAI.0b013e318163bd70
Source: PubMed

ABSTRACT Retrospective cohort studies of HIV-infected patients suggest an incidence of venous thromboembolism (VTE) of 1% to 2%, which is 10 times that expected among people without HIV. We investigated the prevalence of established risk factors for VTE in this population and explored novel risk factors.
We conducted a case-control study using patients in the Johns Hopkins University AIDS Service cohort. We used conditional logistic regression and paired t tests to test for covariates significantly associated with VTE.
We identified 160 patients with VTE diagnosed radiologically or with a clinical course consistent with VTE; 23% of the cases of VTE were diagnosed in hospitalized patients. The incidence of VTE was approximately 0.5% per patient-year. Patients with VTE and control patients did not differ by gender, but black patients were overrepresented among those with VTE (odds ratio [OR]=1.9, 95% confidence interval [CI]: 1.11 to 3.08) and patients with VTE were older than controls (mean: 39 vs. 37 years; P=0.001). Patients with VTE had lower CD4 counts (229 vs. 362 cells/mm; P<0.0001), higher HIV RNA titers (120,254 vs. 71,262 copies/mL; P=0.013), and lower hemoglobin concentrations (11.4 vs. 12.7 g/dL; P<0.0001) preceding the event than those without VTE. The use of highly active antiretroviral therapy was not associated with VTE. In multivariate analyses, independent risks for VTE were age, hospitalization in the past 3 months (OR=13, 95% CI: 6.4 to 27), central venous catheter use in the past 3 months (OR=6.0, 95% CI: 2.3 to 16), and a CD4 count<500 cells/mm (OR=3.0, 95% CI: 1.2 to 7.8).
The incidence of VTE in our cohort is similar to that reported in other cohorts of patients with HIV. Recent hospitalization was the risk factor most strongly associated with VTE.

Download full-text


Available from: Michael B Streiff, Jul 06, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: L’infection par le virus de l’immunodéficience humaine (VIH) peut provoquer des complications vasculaires. Il s’agit le plus souvent de thrombose veineuse des membres inférieurs. De rares cas d’ischémie des membres révélatrice de l’infection à VIH ont été décrits. Nous rapportons un cas de thrombose veineuse du membre inférieur gauche et d’une ischémie artérielle bilatérale des membres inférieurs révélant une infection par le VIH 1 chez une patiente de 44 ans. Le taux de CD4 était de 195/mm3. L’exploration de la coagulation n’a pu être réalisée. La patiente a été amputée de ses deux membres inférieurs.
    Bulletin de la Société de pathologie exotique 106(1). DOI:10.1007/s13149-012-0273-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: In radio links, the periscope antenna is used mainly to avoid terrain obstructions. This type of antenna comprises of a parabolic reflector located on the ground which radiates vertically and illuminates a passive reflector located at the top of a pylon. This passive reflector reflects the beam in the desired direction. Most of the studies about periscope antenna concern the gain problems and rarely the radiation pattern. Due to the large dimension of the periscope antenna, it is very difficult to investigate the radiation patterns. Our studies at millimetric wavelengths allow to reduce these dimensions. So that the radiation patterns of a periscope antenna over 360° can be measured and conclusions can be drawn concerning the influence of periscope antenna parameters :height, shape and dimensions of the passive reflector and, also, the effects of the support and the pylon.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: HIV-infected women are at increased risk for cervical dysplasia. Cervical dysplasia is caused by persistent infections with certain types of human papillomavirus (HPV). Conventional testing for genital HPV infections requires cervical cytology. A non-invasive screening method by detection of HPV DNA in urine samples is preferable but is not a routine practice. To investigate the prevalence and concordance of HPV in paired urine and cervical smear samples and cytological results of Pap smears in HIV-infected women. Paired urine and cervical smear samples were collected from 27 HIV-infected women. The HPV prevalence in urine and cervical smear samples was 81.5% and 51.9%, respectively (p = 0.01). The concordance for HPV positivity and negativity between urine and cervical smear samples is 71%. Seven women (25.9%) had an abnormal cervical smear of Pap II or higher. In all urine samples from these cases HPV DNA was detected. In the present study we show that the HPV prevalence in urine and cervical smear samples of HIV-infected women is high and HPV test results are highly concordant. Therefore, urine samples can be used as medium for HPV testing. HPV testing in urine samples is a simple, reliable, non-invasive screening method.
    Journal of Clinical Virology 03/2008; 41(2):111-5. DOI:10.1016/j.jcv.2007.10.007 · 3.47 Impact Factor